Development of novel licochalcone A and coumarin derivatives to mitigate the amyloid beta aggregation-induced Alzheimer’s disease
碩士 === 國立臺灣師範大學 === 生命科學系 === 105 === Alzheimer's disease (AD), the most common type of dementia in humans, is characterized as a progressive decline in cognitive function and loss of the long-term memory. The prominent pathological features of AD are aggregation of β-amyloid (Aβ) peptide in pl...
Main Authors: | Lee, Shin-Ying, 李欣穎 |
---|---|
Other Authors: | Lee-Chen, Guey-Jen |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/d362ed |
Similar Items
-
Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer’s disease
by: Qiulan Zhang, et al.
Published: (2019-12-01) -
Crocus-derived compounds alter the aggregation pathway of Alzheimer’s Disease: associated beta amyloid protein
by: Nikolaos Stavros Koulakiotis, et al.
Published: (2020-10-01) -
Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
by: Huong T. T. Phan, et al.
Published: (2019-03-01) -
The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
by: Vilaprinyó Pascual, Sílvia
Published: (2015) -
Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
by: Sharmin Reza Chowdhury, et al.
Published: (2019-08-01)